Quantum量子訊息有限公司
← 最新全球產業報告

Hemorrhoid Cream Market

研究執行與發布:Verified Market Research · 發布日期 2026-02-13 · 150 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 Verified Market Research產業別 Healthcare & Life Sciences出版日期 2026-02-13頁數 150報告編號 542109

授權報價

Single User$3,950 USD
Multi User$4,850 USD
Enterprise / Global Site Licence$7,550 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Hemorrhoid Cream Market Size By Type (Prescription Drugs, Over-The-Counter Drugs), By Drug Formulation (Creams and Ointments, Suppositories, Wipes and Pads), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geographic Scope And Forecast

報告摘要

Hemorrhoid Cream Market Overview The hemorrhoid cream market is advancing steadily, driven by the rising prevalence of lifestyle-related digestive issues, aging populations, and growing awareness of over-the-counter treatment options that provide localized relief. Adoption is increasing as consumers seek non-invasive solutions for pain, itching, and inflammation, while healthcare providers continue to recommend topical formulations as first-line management for mild to moderate cases. Demand is supported by wider pharmacy access, e-commerce growth, and preference for self-care products that offer convenience and discretion. Market momentum is shaped by ongoing improvements in formulation comfort, ingredient profiles, and packaging formats, which are broadening consumer acceptance across retail and clinical channels while supporting gradual price balance. Market size – VMR Analyst Corridor Approach A revenue convergence corridor is emerging across recent global assessments instead of relying on a single-point estimate. Market value is consolidating around USD 1.26 Billion during 2025, while long-term projections are extending toward USD 1.83 Billion by 2033, reflecting mid- to high-single-digit growth momentum. A CAGR of 4.8% is being recorded over the forecast period (2027-2033), underscoring the market's structurally resilient growth trajectory. Hemorrhoid Cream Market is estimated to grow at a CAGR 4.8% & reach USD 1.83 Bn by the end of 2033 Global Hemorrhoid Cream Market Definition The hemorrhoid cream market incorporates the development, production, distribution, and deployment of topical formulations used to relieve symptoms associated with hemorrhoids, typically where pain relief, inflammation reduction, and skin protection are required. Product scope includes medicated and non-medicated creams containing anesthetics, corticosteroids, vasoconstrictors, and herbal ingredients offered across varying strengths for over-the-counter and prescription use. Market activity spans pharmaceutical manufacturers, contract formulators, raw material suppliers, and solution providers serving hospitals, clinics, retail pharmacies, online pharmacies, and healthcare practitioners. Demand is shaped by symptom severity, formulation effectiveness, safety profile, and ease of application, while sales channels include retail drugstores, e-commerce platforms, hospital pharmacies, and direct supply agreements supporting ongoing consumer use. Global Hemorrhoid Cream Market Drivers The market drivers for the hemorrhoid cream market can be influenced by various factors. These may include: Demand from Symptomatic Relief and OTC Treatment Applications High demand for symptomatic relief and OTC treatment applications is driving the hemorrhoid cream market, as the rising incidence of lifestyle-related digestive issues increases consumer usage. Preference for non-prescription topical solutions supports steady retail sales. Quick relief positioning reinforces repeat purchases among chronic users. Broad availability across pharmacies supports consistent demand. Rising Global Prevalence of Hemorrhoidal Disease The rising global prevalence of hemorrhoidal disease, affecting daily quality of life, is boosting the hemorrhoid cream market. A systematic review published in PMC indicates that haemorrhoidal disease has a global pooled point prevalence of 25.92% across 8.96 million individuals from 150 studies, with lifetime prevalence at 27.19% among adults worldwide. This widespread condition is driving demand for accessible topical treatments in urban centers such as New York and Mumbai. Expansion of Retail Pharmacy and E-commerce Distribution Channels The rising expansion of retail pharmacy and e-commerce distribution channels is strengthening the market growth, as online platforms and organized pharmacies improve product access. Increased digital health purchases strengthen regional demand patterns. Subscription and refill options support purchase frequency. Long-term distribution agreements improve volume stability and market visibility. Rising Health Risk Factors Increasing risk factors like obesity, pregnancy, and sedentary lifestyles are accelerating market growth. The same PMC meta-analysis identifies older age, obesity, pregnancy, diabetes, and constipation as key risk factors, with females showing a higher prevalence (27.33%) than males (25.72%) and internal hemorrhoids affecting 26.85% of cases. These demographic trends are fueling over-the-counter cream sales for symptom relief. Global Hemorrhoid Cream Market Restraints Several factors act as restraints or challenges for the hemorrhoid cream market. These may include: Volatility in Active Ingredient Supply High volatility in active ingredient supply is restraining the hemorrhoid cream market, as inconsistent availability of botanical extracts, anesthetics, and corticosteroids disrupts production planning across pharmaceutical and OTC manufacturers. Fluctuating input supply introduces uncertainty within procurement cycles and inventory control. Contract stability is under pressure, as long-term sourcing agreements remain difficult amid variable supplier output. Production scalability faces constraints in regions dependent on imported pharmaceutical ingredients. Stringent Regulatory and Compliance Requirements Stringent regulatory and compliance requirements are limiting market expansion, as topical formulations must meet safety, labeling, and clinical validation standards set by health authorities. Compliance-related expenses increase operating costs for manufacturers and distributors. Extended approval and review timelines slow the launch of new formulations and line extensions. Regulatory differences across regions complicate cross-border distribution and market entry planning. Limited Awareness and Social Stigma Limited awareness and social stigma are slowing demand growth, as many consumers delay treatment due to discomfort discussing symptoms or limited understanding of available products. Marketing and educational outreach constraints reduce visibility across new consumer groups. Reliance on self-care without medical consultation persists among conservative buyers. Market penetration across developing regions progresses at a measured pace under restricted awareness levels. High Formulation and Manufacturing Costs High formulation and manufacturing costs are restricting wider adoption, as quality-controlled production, stability testing, and specialized packaging raise overall unit costs. Price-sensitive consumers reassess purchase frequency under sustained pricing pressure. Margin tightening influences pricing strategies and promotional spending. Investment interest in lower-cost home remedies and alternative treatments increases competitive pressure within the market. Global Hemorrhoid Cream Market Opportunities The landscape of opportunities within the hemorrhoid cream market is driven by several growth-oriented factors and shifting global demands. These may include: Increasing Awareness Through Preventive Healthcare Education Increasing awareness through preventive healthcare education is creating strong opportunities for the hemorrhoid cream market, as consumers become more informed about anorectal health. Public health campaigns and physician counseling are encouraging earlier symptom management. Educational content reduces hesitation around seeking topical treatment. Early-stage care adoption supports repeat product use. Preventive focus helps normalize regular purchase behavior. Growth in Geriatric and Sedentary Population Segments Rising growth in geriatric and sedentary population segments is supporting market demand, as age-related vascular weakness and low mobility raise incidence rates. Prolonged sitting associated with desk-based work also contributes to higher usage. Targeted formulations addressing sensitive skin are gaining preference. Demographic trends support consistent consumption patterns. Long-term symptom recurrence sustains market continuity. Product Innovation in Formulations and Delivery Formats Ongoing product innovation in formulations and delivery formats is generating new opportunities, as manufacturers introduce fast-acting and low-irritation variants. Combination creams addressing pain, itching, and inflammation improve consumer satisfaction. Improved applicator designs support hygienic use. Texture and absorption improvements influence brand switching. Innovation supports differentiation in competitive retail environments. Influence of Physician Recommendation and Brand Trust Strong influence of physician recommendation and brand trust is strengthening market presence, as patients often rely on familiar products for recurring conditions. Established brands benefit from repeat prescriptions and word-of-mouth acceptance. Trust in safety profiles supports continued usage without hesitation. Consistent clinical backing reinforces consumer confidence. Brand loyalty supports stable sales volumes over time. Global Hemorrhoid Cream Market Segmentation Analysis The Global Hemorrhoid Cream Market is segmented based on Type, Drug Formulation, End-User, and Geography. Hemorrhoid Cream Market, By Type Prescription Drugs: Prescription drugs are maintaining steady demand in the hemorrhoid cream market, as moderate to severe cases require physician-guided treatment and clinically tested formulations. Usage is supported by hospital pharmacies and specialist consultations where higher-strength corticosteroids, anesthetics, or combination therapies are recommended. Trust in medically supervised products supports consistent consumption. Demand from patients seeking controlled and targeted relief sustains this segment. Over-The-Counter Drugs: Over-the-counter drugs are dominating the market, as easy accessibility and self-care preferences drive high-volume usage. Mild symptom management through creams and ointments available at retail pharmacies and online platforms supports frequent purchases. Preference for fast relief, affordability, and discreet availability encourages repeat use. Wide product variety and strong retail presence reinforce demand across this segment. Hemorrhoid Cream Market, By Drug Formulation Creams and Ointments: Creams and ointments are dominating the hemorrhoid cream market, as topical application provides direct relief from pain, itching, and inflammation. Ease of use and fast local action support high consumer preference across mild to moderate cases. Wide availability through retail pharmacies and online channels encourages frequent purchases. Preference for soothing, fast-absorbing formulations sustains strong demand from this segment. Suppositories: Suppositories are witnessing steady growth, driven by their effectiveness in treating internal hemorrhoids. Targeted delivery of active ingredients supports symptom control where topical creams are less effective. Usage is commonly guided by healthcare professionals, supporting consistent consumption. Demand from patients seeking longer-lasting internal relief reinforces segment growth. Wipes and Pads: Wipes and pads are experiencing gradual expansion, as hygienic and convenient symptom management gains wider acceptance. Usage before or after topical treatment supports cleanliness and comfort. Growing availability of medicated and soothing wipe options encourages adoption. Preference for gentle, disposable solutions supports regular use within daily care routines. Hemorrhoid Cream Market, By End-User Hospital Pharmacies: Hospital pharmacies are witnessing substantial growth in the hemorrhoid cream market, as physician-prescribed treatments and post-consultation purchases support consistent usage. Availability of prescription-strength formulations and supervised dispensing encourages patient reliance on hospital channels. Treatment of moderate to severe cases within clinical settings sustains regular procurement. Trust in medically guided therapy supports ongoing demand from this end-user segment. Retail Pharmacies: Retail pharmacies are dominating the market, as easy access and over-the-counter availability drive high purchase volumes. Consumers prefer local pharmacies for quick relief products and pharmacist recommendations. Wide shelf presence of branded and generic formulations supports repeat buying behavior. Convenience and immediate availability reinforce strong demand from this segment. Online Pharmacies: Online pharmacies are experiencing steady demand, as discreet purchasing and home delivery options increase consumer adoption. Digital health platforms and e-commerce penetration support wider product access across urban and semi-urban areas. Competitive pricing and subscription-based purchasing encourage repeat orders. Growing comfort with online healthcare shopping sustains expansion within this end-user segment. Hemorrhoid Cream Market, By Geography North America: North America dominates the hemorrhoid cream market, as high awareness of anorectal conditions and strong over-the-counter medication usage support steady demand. Advanced healthcare infrastructure and widespread access to pharmacies and online drugstores are witnessing consistent product uptake in cities such as New York and Chicago. Preference for fast-acting topical relief and physician-recommended formulations is encouraging repeat purchases. The presence of major pharmaceutical brands and regulated distribution channels reinforces the regional market size. Europe: Europe is witnessing substantial growth, driven by rising diagnosis rates and increasing self-care practices across aging populations. Strong regulatory standards support consistent formulation quality and consumer trust, with notable demand across urban centers such as London and Berlin. Expanding retail pharmacy networks and private-label product availability sustain regular consumption. Public health awareness campaigns contribute to steady market expansion. Asia Pacific: Asia Pacific is experiencing a surge, as large population bases and growing awareness of gastrointestinal health drive higher product usage. Rapid urbanization and changing dietary patterns are witnessing an increasing demand in cities like Shanghai and Mumbai. Expanding pharmaceutical manufacturing capacity and competitive pricing support wide market penetration. Rising retail pharmacy access and online sales channels are strengthening the regional market size. Latin America: Latin America is noticing steady demand, as improving healthcare access and rising consumer comfort with topical treatments increase demand for hemorrhoid creams. Urban healthcare development in cities such as São Paulo and Buenos Aires supports consistent product availability. Growing pharmacy chains and regional drug manufacturers are supporting gradual volume growth. Demand from adult and elderly populations contributes to market expansion. Middle East and Africa: The Middle East and Africa are primed for expansion, as expanding healthcare services and pharmacy networks support selective demand. Urban centers such as Dubai and Johannesburg are witnessing higher adoption due to improved medical access. Import-based product supply supports stable consumption patterns. Increasing focus on personal health management is strengthening long-term regional demand. Key Players The competitive environment is remaining brand-driven, with established players leveraging distribution scale, product breadth, and brand trust. Competitive differentiation is shifting toward material transparency, comfort-led design, and sustainability positioning, while portfolio consolidation and brand acquisition activity are reshaping ownership dynamics. Key Players Operating in the Global Hemorrhoid Cream Market Johnson & Johnson Mayinglong eXroid Sun Pharmaceutical Industries AdvaCare Pharma Bausch Health RectiCare Medline Industries
目錄 Table of Contents
1 INTRODUCTION 1.1 MARKET DEFINITION 1.2 MARKET SEGMENTATION 1.3 RESEARCH TIMELINES 1.4 ASSUMPTIONS 1.5 LIMITATIONS 2 RESEARCH METHODOLOGY 2.1 DATA MINING 2.2 SECONDARY RESEARCH 2.3 PRIMARY RESEARCH 2.4 SUBJECT MATTER EXPERT ADVICE 2.5 QUALITY CHECK 2.6 FINAL REVIEW 2.7 DATA TRIANGULATION 2.8 BOTTOM-UP APPROACH 2.9 TOP-DOWN APPROACH 2.10 RESEARCH FLOW 2.11 DATA AGE GROUPS 3 EXECUTIVE SUMMARY 3.1 GLOBAL HEMORRHOID CREAM MARKET OVERVIEW 3.2 GLOBAL HEMORRHOID CREAM MARKET ESTIMATES AND FORECAST (USD BILLION) 3.3 GLOBAL HEMORRHOID CREAM MARKET ECOLOGY MAPPING 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM 3.5 GLOBAL HEMORRHOID CREAM MARKET ABSOLUTE MARKET OPPORTUNITY 3.6 GLOBAL HEMORRHOID CREAM MARKET ATTRACTIVENESS ANALYSIS, BY REGION 3.7 GLOBAL HEMORRHOID CREAM MARKET ATTRACTIVENESS ANALYSIS, BY TYPE 3.8 GLOBAL HEMORRHOID CREAM MARKET ATTRACTIVENESS ANALYSIS, BY DRUG FORMULATION 3.9 GLOBAL HEMORRHOID CREAM MARKET ATTRACTIVENESS ANALYSIS, BY END USER 3.10 GLOBAL HEMORRHOID CREAM MARKET GEOGRAPHICAL ANALYSIS (CAGR %) 3.11 GLOBAL HEMORRHOID CREAM MARKET, BY TYPE (USD BILLION) 3.12 GLOBAL HEMORRHOID CREAM MARKET, BY DRUG FORMULATION (USD BILLION) 3.13 GLOBAL HEMORRHOID CREAM MARKET, BY END USER (USD BILLION) 3.14 GLOBAL HEMORRHOID CREAM MARKET, BY GEOGRAPHY (USD BILLION) 3.15 FUTURE MARKET OPPORTUNITIES 4 MARKET OUTLOOK 4.1 GLOBAL HEMORRHOID CREAM MARKET EVOLUTION 4.2 GLOBAL HEMORRHOID CREAM MARKET OUTLOOK 4.3 MARKET DRIVERS 4.4 MARKET RESTRAINTS 4.5 MARKET TRENDS 4.6 MARKET OPPORTUNITY 4.7 PORTER’S FIVE FORCES ANALYSIS 4.7.1 THREAT OF NEW ENTRANTS 4.7.2 BARGAINING POWER OF SUPPLIERS 4.7.3 BARGAINING POWER OF BUYERS 4.7.4 THREAT OF SUBSTITUTE GENDERS 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS 4.8 VALUE CHAIN ANALYSIS 4.9 PRICING ANALYSIS 4.10 MACROECONOMIC ANALYSIS 5 MARKET, BY TYPE 5.1 OVERVIEW 5.2 GLOBAL HEMORRHOID CREAM MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY TYPE 5.4 PRESCRIPTION DRUGS 5.5 OVER-THE-COUNTER DRUGS 6 MARKET, BY DRUG FORMULATION 6.1 OVERVIEW 6.2 GLOBAL HEMORRHOID CREAM MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY DRUG FORMULATION 6.3 CREAMS AND OINTMENTS 6.4 SUPPOSITORIES 6.5 WIPES AND PADS 7 MARKET, BY END USER 7.1 OVERVIEW 7.2 GLOBAL HEMORRHOID CREAM MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END USER 7.3 HOSPITAL PHARMACIES 7.4 RETAIL PHARMACIES 7.5 ONLINE PHARMACIES 8 MARKET, BY GEOGRAPHY 8.1 OVERVIEW 8.2 NORTH AMERICA 8.2.1 U.S. 8.2.2 CANADA 8.2.3 MEXICO 8.3 EUROPE 8.3.1 GERMANY 8.3.2 U.K. 8.3.3 FRANCE 8.3.4 ITALY 8.3.5 SPAIN 8.3.6 REST OF EUROPE 8.4 ASIA PACIFIC 8.4.1 CHINA 8.4.2 JAPAN 8.4.3 INDIA 8.4.4 REST OF ASIA PACIFIC 8.5 LATIN AMERICA 8.5.1 BRAZIL 8.5.2 ARGENTINA 8.5.3 REST OF LATIN AMERICA 8.6 MIDDLE EAST AND AFRICA 8.6.1 UAE 8.6.2 SAUDI ARABIA 8.6.3 SOUTH AFRICA 8.6.4 REST OF MIDDLE EAST AND AFRICA 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 9.2 KEY DEVELOPMENT STRATEGIES 9.3 COMPANY REGIONAL FOOTPRINT 9.4 ACE MATRIX 9.4.1 ACTIVE 9.4.2 CUTTING EDGE 9.4.3 EMERGING 9.4.4 INNOVATORS 10 COMPANY PROFILES 10.1 OVERVIEW 10.2 JOHNSON & JOHNSON 10.3 MAYINGLONG 10.4 EXROID 10.5 SUN PHARMACEUTICAL INDUSTRIES 10.6 ADVACARE PHARMA 10.7 BAUSCH HEALTH 10.8 RECTICARE 10.9 MEDLINE INDUSTRIES

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Verified Market Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們